(HealthDay)—The risk for breast cancer recurrence can be extracted using disease-specific survival data, according to a study published online Oct. 18 in Cancer Epidemiology, Biomarkers & Prevention.
Bottom Line: A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results